NCT00937534View on ClinicalTrials.gov

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Essential Hypertension
Interventions
DRUG

Fimasartan

Fimasartan 240mg/day

Sponsors
All Listed Sponsors
collaborator

Kyungpook National University Hospital

OTHER

collaborator

Seoul National University Hospital

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT00937534 - Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers | Biotech Hunter | Biotech Hunter